General Information
DRAVP ID DRAVPe02272
Peptide Name Labyrinthopeptin A2
Sequence SDWSLWECCSTGSLFACC
Sequence Length 18
UniProt ID C0MP60
Taxon ID 182080
Source A.namibiensis
Validation Experimentally Validated
Origin Information
Gene Name/ID labA2
GenBank Not Available
Amino Acid position 21-38
Domain Accession ID Not Available
Nucleotide sequence ID Not Available
Molecular Type Not Available
Chromosomal Position Not Available
Activity Information
Target Organism DENV,ZIKV,WNV,HCV,CHIKV,KSHV,CMV,HSV
Assay Antiviral Assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Membrane
Mechanism LabyA2 exert the antiviral function by disrupting viral envelopes (virolysis).
Structure Information
PDB ID None
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C85H120N20O28S4
Absent amino acids RNQHIKMPYVOU
Common amino acids CS
Mass 1998.24
Pl 3.67
Basic residues 0
Acidic residues 2
Hydrophobic residues 6
Net charge -2
Boman Index 0.35
Hydrophobicity 0.506
Aliphatic Index 48.89
Half Life
Extinction Coefficient cystines 11250
Absorbance 280nm 5.63
Polar residues 10
Literature Information
Literature 1
Title Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis
Pubmed ID 31666384
Reference Journal of virology, 94(2), e01471-19
Author Prochnow, H., Rox, K., Birudukota, N. V. S., Weichert, L., Hotop, S. K., Klahn, P., Mohr, K., Franz, S., Banda, D. H., Blockus, S., Schreiber, J., Haid, S., Oeyen, M., Martinez, J. P., Süssmuth, R. D., Wink, J., Meyerhans, A., Goffinet, C., Messerle, M., Schulz, T. F., … Brönstrup, M. (2020).